Send us Feedback

Hollis-Eden Pharmaceuticals (HEPH)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009
Cash & Equivalents 29.1M 24.2M 20.1M 15.2M 12.1M
Short Term Investments 0 0 0 0 0
Accounts Receivable 0 0 0 0 19.0K
Inventories 0 0 0 0 0
Pre-paid Expenses 249K 262K 153K 581K 397K
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 9000 0 61.0K 61.0K 61.0K
Total Current Assets 29.3M 24.4M 20.3M 15.8M 12.6M
Property, Plant & Equipment 726K 641K 562K 502K 421K
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 95.0K 95.0K 34.0K 0 0
Total Long-Term Assets 821K 736K 596K 502K 421K
Accounts Payable 762K 323K 724K 282K 305K
Accrued Expenses 1.94M 0 0 0 0
Short Term Debt 0 0 0 0 0
Long Term Debt 0 0 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 0 0 0 0 0
Minority Interest 0 0 0 0 0
Total Liabilities 2.71M 1.95M 2.65M 1.84M 1.63M
Preferred Stock 0 0 0 0 0
Common Par 291K 292K 292K 293K 294K
Additional Paid-In Capital 259M 259M 260M 260M 261M
Retained Earnings -231M -236M -242M -246M -249M
Treasury Stock -346K -346K -346K -346K -346K
Other Equity 0 0 0 0 0
Total Shareholder's Equity 27.4M 23.2M 18.3M 14.5M 11.4M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki